A significant shortage of influenza vaccine occurred in the U.S.
On Aug. 25, 2004, a significant shortage of influenza vaccine occurred in the U.S. as a result of…
On Aug. 25, 2004, a significant shortage of influenza vaccine occurred in the U.S. as a result of…
On May 27, 2004, the National Institute of Allergy and Infectious Diseases (NIAID) announced it had awarded contracts…
On Oct. 15, 2003, the Immunization Practices Advisory Committee (ACIP) voted to recommend that children 6 to 23…
On Jun. 17, 2003, the first nasally administered influenza vaccine (FluMist by MedImmune) was licensed. This live influenza…
On Jan. 1, 2003, the Advisory Committee on Immunization Practices (ACIP) encouraged that children 6 to 23 months…
In 2003, public health officials reported the re-emergence of H5N1 avian influenza for the first time since an…
On Oct. 27, 1999, Hoffmann-La Roche and Gilead Sciences announced that Roche’s TAMIFLU (oseltamivir phosphate) had been approved…
On Oct. 27, 1999, Hoffmann-La Roche and Gilead Sciences announced that Roche’s TAMIFLUâ„¢ (oseltamivir phosphate) has been approved…
In April 1999, a pandemic planning framework was published by the World Health Organization (WHO) that emphasized the…
In 1998, the U.S. Department of Agriculture (USDA) began surveillance of swine for influenza virus in the U.S….
In 1997, FluNet, a global web-based tool for influenza virological surveillance was launched. It is a critical tool…
In 1997, the H5N1 bird flu incident in Hong Kong was the first known instance of a purely…
On Oct. 2, 1996, the Food and Drug Administration (FDA) licensed a combined Hib conjugate and hepatitis B…
In 1996, A/goose/Guangdong/1/1996 (H5N1), the precursor of the highly pathogenic H5N1 avian influenza viruses (HPAIVs) was identified in…
In 1994, Rimantadine, derived from amantadine, was approved by the Food and Drug Administration (FDA) to treat influenza…
On May 1, 1993, the costs of influenza vaccine and its administration became a covered benefit under Medicare…
On Mar. 30, 1993, the U.S. Food and Drug Administration (FDA) approved a new Haemophilus b conjugate vaccine,…
On Mar. 1, 1993, the combined Haemophilus influenzae type b vaccine and whole cell DTP vaccine (Tetramune by…
In 1993, the U.S. Centers for Disease Control and Prevention (CDC) responded to the H5N1 avian flu outbreak…
On Dec. 13, 1990, the U.S. Food and Drug Administration (FDA) approved Haemophilus b Conjugate Vaccine (Meningococcal Protein…
On Oct. 4, 1990, the FDA approved the use of Haemophilus b Conjugate Vaccine (Diphtheria CRM 197 Protein…
On Dec. 21, 1988, the conjugated Haemophilus influenzae type b vaccine (HibTITER by Wyeth-Lederle) was licensed. Prior to…
On Dec. 22, 1987, the protein-conjugated Haemophilus influenzae type b vaccine (PRP-D, ProHibit by Connaught) was licensed.
On Apr. 12, 1985, the Haemophilus influenzae type b (Hib) polysaccharide vaccines (b-CAPSA 1 by Praxis Biologics, Hib-VAX…
In 1981, the U.S. Centers for Disease Control and Prevention (CDC) began collecting reports of influenza outbreaks from…
On Oct. 13, 1976, the swine flu vaccination program in the U.S. was suspended following reports of paralysis. …
In 1976, Influenza A/Victoria-like strains had been identified in New Jersey as early as January 21. The novel…
In 1976, the U.S. Centers for Disease Control and Prevention (CDC) was involved in a national immunization program…
In 1970, influenza H3N2 viruses were first identified in swine during an influenza surveillance study in Taiwan. This…
The 1968 pandemic, also known as the Hong Kong flu, was caused by an influenza A (H3N2) virus…